Description

Ocrelizumab is a monoclonal antibody used in the treatment of multiple sclerosis. It works by targeting and depleting certain immune cells that are involved in the disease process, thereby reducing inflammation and nerve damage.

Interpreter Notes

Interpreters may encounter variations such as 'Ocrelizumab' pronounced differently or mistakenly referred to as a different medication. It is crucial to maintain a formal register and ensure clarity when discussing this treatment, as it is specific to multiple sclerosis.

Example Sentences

EN: The doctor prescribed Ocrelizumab to manage the patient's relapsing forms of multiple sclerosis.

ES: El médico prescribió Ocrelizumab para manejar las formas recurrentes de esclerosis múltiple del paciente.

Common Interpreter Mistakes

Confusing Ocrelizumab with other similar-sounding medications; mispronouncing Ocrelizumab; using informal language when discussing the medication.